Q2 2016
Released Aug 9, 2016, before the open
10-Q filed Aug 9, 2016, 40 days after period end · 0001144204-16-117433
Q2 2016 · 10-Q
Revenue—
Net Income-$5.76M-$5.76M N/M vs Q2 2015N/M vs Q1 2016
EPS Diluted-$0.32-$0.32 N/M vs Q2 2015N/M vs Q1 2016
Operating Income-$5,815,120N/M
Operating Cash Flowderived-$5,176,218N/M
Free Cash Flowderived-$5,196,666N/M
What the release said
The release
Same quarter
| Metric | Q2 2016 | Q2 2015 | Q2 2014 | Q2 2013 |
|---|---|---|---|---|
| Net Income | -$5.76M | -$4.25M | -$6.97M | -$1.37M |
| EPS Diluted | -$0.32 | -$0.26 | -$0.55 | -$0.31 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Lipocine Inc. · CIK 1535955 · Engraved from SEC EDGAR